The feasibility and effects of mindfulness based relapse prevention (MBRP) on reducing craving and addictive behaviour in substance abuse disorders

The feasibility and effects of mindfulness based relapse prevention (MBRP) on reducing craving and addictive behaviour in local adults with substance abuse disorders

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026247

Enrollment

Unknown

Registered

2019-09-28

Start date

2019-10-10

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorder

Interventions

Experimental group:MBRP intervention

Control Group:Usual Care

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 70 years; 2. Fluent in Cantonese; 3. Has fulfilled the Structured Clinical interview for DSM(SCID) for substance use disorder diagnoses; 4. Has completed outpatient or inpatient treatment for substance abuse in the previous 6 months.

Exclusion criteria

Exclusion criteria: 1. Inability to provide valid consent; 2. Current or lifetime psychotic disorder diagnosed by the Structured Clinical interview for DSM-IV or DSM-5 - Imminent suicidal risk; 3. Dementia.

Design outcomes

Primary

Measure	Time frame
Substance Use Calender (self-report);Urine test;	—

Secondary

Measure	Time frame
Drug Craving (Penn Alcohol Craving Scale);Depression (PHQ-9);Anxiety (GAD-7);Addiction Severity (Addiction Severity Index - Lite Version);Drug Avoidance Self-Efficacy (Drug Avoidance Self-Efficacy Scale);Level of Acceptance (Acceptance and Action Questionnaire);Level of Mindfulness (Five Facet Mindfulness Questionnaire);Meditation Practice (worksheet reporting type and duration of mindfulness practice);Health Related Quality of Life (EuroQol Eq-5D-5L);Interview (one hour, open ended questions on perceived practice of mindfulness course);	—

Measure

Time frame

Drug Craving (Penn Alcohol Craving Scale);Depression (PHQ-9);Anxiety (GAD-7);Addiction Severity (Addiction Severity Index - Lite Version);Drug Avoidance Self-Efficacy (Drug Avoidance Self-Efficacy Scale);Level of Acceptance (Acceptance and Action Questionnaire);Level of Mindfulness (Five Facet Mindfulness Questionnaire);Meditation Practice (worksheet reporting type and duration of mindfulness practice);Health Related Quality of Life (EuroQol Eq-5D-5L);Interview (one hour, open ended questions on perceived practice of mindfulness course);

—

Countries

China

Contacts

Public ContactSamuel Yeung Shan Wong

Chinese University of Hong Kong

yeungshanwong@cuhk.edu.hk+86 22528753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026